Literature DB >> 5096367

Chemical classes of amyloid substance.

E P Benditt, N Eriksen.   

Abstract

Concentrates of amyloid substance derived from organs of 10 human patients representing a variety of clinical entities were characterized according to their amino acid compositions, their electrophoretic constituents mobile in urea-starch gel at pH 3 and their stability with respect to the binding of Congo red in the pH interval 9-12.5. The analyses revealed the existence of two major classes of amyloid substance. Material from one class, embracing those cases that had a chronic inflammatory disease as the principal associated process (type A amyloidosis), had a similar amino acid composition and was distinguished by the presence in the amyloid substance of a large amount of an electrophoretically well-defined group of low-molecular-weight proteins with an unusual amino acid composition (amyloid protein A); type A amyloid substance lost the typical binding of Congo red dye at pH 11.5 or lower. Concentrates of amyloid substance in the other class (type B amyloidosis), represented by a case of multiple myeloma, 3 other cases of neoplastic disease and a case of primary cardiac amyloidosis, were distinguished by the presence of an electrophoretically more heterogeneous group of protein constituents with different mobilities and with apparently higher molecular weights than that of protein A, by an amino acid composition that is clearly different from that of the first class, and by retention of the typical Congo red-binding property at pH 12 or higher. The major constituent, protein A, of amyloid substances of the first class is clearly different from ordinary fragments of immunoglobulins in size, electrophoretic mobility, and amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5096367      PMCID: PMC2047520     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  AMYLOID. II. STARCH GEL ELECTROPHORETIC ANALYSIS OF SOME PROTEINS EXTRACTED FROM AMYLOID.

Authors:  E P BENDITT; N ERIKSEN
Journal:  Arch Pathol       Date:  1964-10

2.  Amyloid. Extraction and preliminary characterization of some proteins.

Authors:  E P BENDITT; D LAGUNOFF; N ERIKSEN; O A ISERI
Journal:  Arch Pathol       Date:  1962-10

3.  Studies on structural units of the gamma-globulins.

Authors:  G M EDELMAN; M D POULIK
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

4.  Colour Standards for use in the Determination of Iminazoles.

Authors:  G Hunter
Journal:  Biochem J       Date:  1925       Impact factor: 3.857

Review 5.  The antibody problem.

Authors:  G M Edelman; W E Gall
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

Review 6.  Amyloidosis.

Authors:  A S Cohen
Journal:  N Engl J Med       Date:  1967-09-07       Impact factor: 91.245

7.  Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma. A distinct genetic entity.

Authors:  R N Schimke; W H Hartmann
Journal:  Ann Intern Med       Date:  1965-12       Impact factor: 25.391

8.  Amyloid. 3. A protein related to the subunit structure of human amyloid fibrils.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

9.  Congo red dichroism with dispersed amyloid fibrils, an extrinsic cotton effect.

Authors:  E P Benditt; N Eriksen; C Berglund
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

10.  The characterization of soluble amyloid prepared in water.

Authors:  M Pras; M Schubert; D Zucker-Franklin; A Rimon; E C Franklin
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

View more
  40 in total

1.  Epithelial induction of serum amyloid A in experimental mucosal inflammation.

Authors:  Kouhei Fukushima; Hitoshi Ogawa; Taku Kitayama; Toshiyuki Yamada; Hiroo Naito; Yuji Funayama; Seiki Matsuno; Iwao Sasaki
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  [Amyloid centers in Europe: the EURAMY project].

Authors:  P Westermark
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

Review 3.  The pathogenesis of amyloidosis: understanding general principles.

Authors:  P Westermark
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 4.  New concepts in the pathogenesis of primary and secondary amyloid disease.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

5.  Comparisons of the texture of amyloid, collagen and Alzheimer cells. A polarization microscopic-histochemical study.

Authors:  D Katenkamp; D Stiller
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973-05-28

6.  Amyloid deposits in bioprosthetic cardiac valves after long-term implantation in man. A new localization of amyloidosis.

Authors:  Y A Goffin; E Gruys; G D Sorenson; F Wellens
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

7.  Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion.

Authors:  T Shirahama; M Skinner; P Westermark; A Rubinow; A S Cohen; A Brun; T L Kemper
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

8.  Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance.

Authors:  N Eriksen; L H Ericsson; N Pearsall; D Lagunoff; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

9.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

10.  Amyloid protein SAA is associated with high density lipoprotein from human serum.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.